THE A1 AND A1(B) PROTEINS OF HETEROGENEOUS NUCLEAR RIBONUCLEOPARTICLES MODULATE 5' SPLICE-SITE SELECTION IN-VIVO

被引:174
作者
YANG, XM
BANI, MR
LU, SJ
ROWAN, S
BENDAVID, Y
CHABOT, B
机构
[1] UNIV SHERBROOKE,FAC MED,DEPT MICROBIOL,SHERBROOKE J1H 5N4,PQ,CANADA
[2] UNIV TORONTO,SUNNYBROOK HLTH SCI CTR,TORONTO M4N 3M5,ON,CANADA
[3] UNIV TORONTO,DEPT MED BIOPHYS,TORONTO M4N 3M5,ON,CANADA
关键词
ALTERNATIVE SPLICING; RNA BINDING PROTEIN; ADENOVIRUS E1A GENE; ERYTHROLEUKEMIA CELLS;
D O I
10.1073/pnas.91.15.6924
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Recent in vitro results suggest that the heterogeneous nuclear ribonucleoparticle (hnRNP) A1 protein modulates alternative splicing by favoring distal 5' splice site (5'SS) selection and exon skipping. We used a mouse erythroleukemia (MEL) cell line (CB3C7) deficient in the expression of hnRNP A1 to test whether variations in hnRNP A1 and A1(B) protein levels affected alternative splicing in vivo. In contrast to A1-expressing MEL cell lines, CB3C7 cells preferentially selected the proximal 13S and 12S 5'SS on the adenovirus E1A pre-mRNA. Transiently expressing the A1 or A1(B) cDNA in CB3C7 cells shifted 5'SS selection toward the more distal 9S donor site. A1 protein synthesis was required for this effect since the expression of a mutated A1 cDNA did not affect 5'SS selection. These results demonstrate that in vivo variations in hnRNP A1 protein levels can influence 5'SS selection.
引用
收藏
页码:6924 / 6928
页数:5
相关论文
共 41 条
[1]   ERYTHROLEUKEMIA INDUCTION BY FRIEND MURINE LEUKEMIA-VIRUS - INSERTIONAL ACTIVATION OF A NEW MEMBER OF THE ETS GENE FAMILY, FLI-1, CLOSELY LINKED TO C-ETS-1 [J].
BENDAVID, Y ;
GIDDENS, EB ;
LETWIN, K ;
BERNSTEIN, A .
GENES & DEVELOPMENT, 1991, 5 (06) :908-918
[2]   IDENTIFICATION AND MAPPING OF A COMMON PROVIRAL INTEGRATION SITE FLI-1 IN ERYTHROLEUKEMIA-CELLS INDUCED BY FRIEND MURINE LEUKEMIA-VIRUS [J].
BENDAVID, Y ;
GIDDENS, EB ;
BERNSTEIN, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (04) :1332-1336
[3]   RETROVIRAL INSERTIONS DOWNSTREAM OF THE HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1 GENE IN ERYTHROLEUKEMIA-CELLS - EVIDENCE THAT A1 IS NOT ESSENTIAL FOR CELL-GROWTH [J].
BENDAVID, Y ;
BANI, MR ;
CHABOT, B ;
DEKOVEN, A ;
BERNSTEIN, A .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (10) :4449-4455
[4]   DIFFERENTIAL BINDING OF HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS TO MESSENGER-RNA PRECURSORS PRIOR TO SPLICEOSOME ASSEMBLY INVITRO [J].
BENNETT, M ;
PINOIROMA, S ;
STAKNIS, D ;
DREYFUSS, G ;
REED, R .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (07) :3165-3175
[5]   PROTEIN-COMPONENTS SPECIFICALLY ASSOCIATED WITH PRESPLICEOSOME AND SPLICEOSOME COMPLEXES [J].
BENNETT, M ;
MICHAUD, S ;
KINGSTON, J ;
REED, R .
GENES & DEVELOPMENT, 1992, 6 (10) :1986-2000
[6]   ISOLATION OF AN ACTIVE GENE ENCODING HUMAN HNRNP PROTEIN-A1 - EVIDENCE FOR ALTERNATIVE SPLICING [J].
BIAMONTI, G ;
BUVOLI, M ;
BASSI, MT ;
MORANDI, C ;
COBIANCHI, F ;
RIVA, S .
JOURNAL OF MOLECULAR BIOLOGY, 1989, 207 (03) :491-503
[7]   INTERACTION OF HNRNP-A1 WITH SNRNPS AND PRE-MESSENGER-RNAS - EVIDENCE FOR A POSSIBLE ROLE OF A1-RNA ANNEALING ACTIVITY IN THE 1ST STEPS OF SPLICEOSOME ASSEMBLY [J].
BUVOLI, M ;
COBIANCHI, F ;
RIVA, S .
NUCLEIC ACIDS RESEARCH, 1992, 20 (19) :5017-5025
[8]   RECOMBINANT HNRNP PROTEIN A1 AND ITS N-TERMINAL DOMAIN SHOW PREFERENTIAL AFFINITY FOR OLIGODEOXYNUCLEOTIDES HOMOLOGOUS TO INTRON EXON ACCEPTOR SITES [J].
BUVOLI, M ;
COBIANCHI, F ;
BIAMONTI, G ;
RIVA, S .
NUCLEIC ACIDS RESEARCH, 1990, 18 (22) :6595-6600
[9]   ALTERNATIVE SPLICING IN THE HUMAN GENE FOR THE CORE PROTEIN-A1 GENERATES ANOTHER HNRNP PROTEIN [J].
BUVOLI, M ;
COBIANCHI, F ;
BESTAGNO, MG ;
MANGIAROTTI, A ;
BASSI, MT ;
BIAMONTI, G ;
RIVA, S .
EMBO JOURNAL, 1990, 9 (04) :1229-1235
[10]   MAMMALIAN HETEROGENEOUS RIBONUCLEOPROTEIN-A1 AND ITS CONSTITUENT DOMAINS - NUCLEIC-ACID INTERACTION, STRUCTURAL STABILITY AND SELF-ASSOCIATION [J].
CASASFINET, JR ;
SMITH, JD ;
KUMAR, A ;
KIM, JG ;
WILSON, SH ;
KARPEL, RL .
JOURNAL OF MOLECULAR BIOLOGY, 1993, 229 (04) :873-889